Immediate Impact
72 standout
Citing Papers
Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
2025 Standout
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Works of Erdinç Nayır being referenced
A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).
2019
Ginseng and cancer.
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Erdinç Nayır | 71 | 36 | 110 | 40 | 29 | 300 | |
| Kyung Im Kim | 66 | 48 | 75 | 37 | 25 | 367 | |
| Bryant Megna | 83 | 33 | 147 | 29 | 23 | 361 | |
| Jinhong Gong | 42 | 25 | 80 | 29 | 34 | 267 | |
| Masami Komiya | 78 | 33 | 162 | 35 | 27 | 319 | |
| Liying Xu | 30 | 31 | 160 | 25 | 18 | 355 | |
| Heba M. Eltahir | 34 | 23 | 146 | 32 | 30 | 340 | |
| Zhao Yuan | 89 | 46 | 145 | 42 | 25 | 334 | |
| AmirAhmad Arabzadeh | 46 | 36 | 140 | 24 | 29 | 301 | |
| Jue Zhang | 80 | 17 | 153 | 21 | 22 | 368 | |
| Pan Cheng-en | 97 | 21 | 137 | 26 | 18 | 363 |
All Works
Login with ORCID to disown or claim papers
Loading papers...